1. Home
  2. ACHL vs RGS Comparison

ACHL vs RGS Comparison

Compare ACHL & RGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACHL
  • RGS
  • Stock Information
  • Founded
  • ACHL 2016
  • RGS 1922
  • Country
  • ACHL United Kingdom
  • RGS United States
  • Employees
  • ACHL N/A
  • RGS N/A
  • Industry
  • ACHL Biotechnology: Biological Products (No Diagnostic Substances)
  • RGS Other Consumer Services
  • Sector
  • ACHL Health Care
  • RGS Consumer Discretionary
  • Exchange
  • ACHL Nasdaq
  • RGS Nasdaq
  • Market Cap
  • ACHL 46.0M
  • RGS 54.5M
  • IPO Year
  • ACHL 2021
  • RGS 1991
  • Fundamental
  • Price
  • ACHL $1.38
  • RGS $21.61
  • Analyst Decision
  • ACHL Buy
  • RGS
  • Analyst Count
  • ACHL 2
  • RGS 0
  • Target Price
  • ACHL $4.00
  • RGS N/A
  • AVG Volume (30 Days)
  • ACHL 1.9M
  • RGS 33.6K
  • Earning Date
  • ACHL 04-03-2025
  • RGS 02-12-2025
  • Dividend Yield
  • ACHL N/A
  • RGS N/A
  • EPS Growth
  • ACHL N/A
  • RGS N/A
  • EPS
  • ACHL N/A
  • RGS 40.46
  • Revenue
  • ACHL N/A
  • RGS $191,336,000.00
  • Revenue This Year
  • ACHL N/A
  • RGS N/A
  • Revenue Next Year
  • ACHL N/A
  • RGS N/A
  • P/E Ratio
  • ACHL N/A
  • RGS $0.59
  • Revenue Growth
  • ACHL N/A
  • RGS N/A
  • 52 Week Low
  • ACHL $0.63
  • RGS $3.87
  • 52 Week High
  • ACHL $1.76
  • RGS $35.50
  • Technical
  • Relative Strength Index (RSI)
  • ACHL 72.41
  • RGS 42.67
  • Support Level
  • ACHL $1.10
  • RGS $23.32
  • Resistance Level
  • ACHL $1.41
  • RGS $24.45
  • Average True Range (ATR)
  • ACHL 0.02
  • RGS 1.86
  • MACD
  • ACHL 0.00
  • RGS -0.29
  • Stochastic Oscillator
  • ACHL 90.48
  • RGS 13.68

About ACHL Achilles Therapeutics plc

Achilles Therapeutics PLC is a biopharmaceutical company. It is developing AI-powered precision T-cell therapies targeting clonal neoantigens to treat solid tumors. The company has two ongoing trials, the CHIRON trial in patients with non-small-cell lung cancer and the THETIS trial in patients with recurrent or metastatic melanoma.

About RGS Regis Corporation

Regis Corp owns, franchises, and operates beauty salons throughout North America and the United Kingdom. The company's locations provide salon products and services to the mass market, including haircutting, styling, and hair coloring. The vast majority of Regis' salons are in strip malls, shopping centers, and Wal-Mart stores in North America and serve price-conscious customers. The company derives the majority of its revenue from these locations. The sale of products also contributes a relatively significant percentage of total sales. Regis also operates a smaller portfolio of premium salons across North America and the U.K. The company's majority brands include SmartStyle, Cost Cutters, and Supercuts.

Share on Social Networks: